Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 401

1.

Hypertension in Metabolic Syndrome: novel insights.

Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V.

Curr Hypertens Rev. 2019 Apr 15. doi: 10.2174/1573402115666190415161813. [Epub ahead of print]

PMID:
30987573
2.

Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.

Athyros VG, Polyzos SA, Kountouras J, Katsiki N, Anagnostis P, Doumas M, Mantzoros CS.

Curr Vasc Pharmacol. 2019 Apr 5. doi: 10.2174/1570161117666190405164313. [Epub ahead of print]

PMID:
30961499
3.

Boosting the limited use of mineralocorticoid receptor antagonists through new agents for hyperkalemia.

Athyros VG, Sachinidis AG, Zografou I, Simoulidou E, Piperidou A, Stavropoulos N, Karagiannis A.

Curr Pharm Des. 2019 Mar 6. doi: 10.2174/1381612825666190306162339. [Epub ahead of print]

PMID:
30848186
4.

Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment.

Katsiki N, Athyros VG.

Curr Med Res Opin. 2019 Mar 1:1-2. doi: 10.1080/03007995.2019.1589152. [Epub ahead of print] No abstract available.

PMID:
30819009
5.

Understanding the cardiovascular risk with non-insulin antidiabetic drugs.

Athyros VG, Imprialos K, Stavropoulos K, Sahinidis A, Doumas M.

Expert Opin Drug Saf. 2019 Mar;18(3):241-251. doi: 10.1080/14740338.2019.1586881. Epub 2019 Mar 8. Review.

PMID:
30810055
6.

Effects of lipid lowering drugs on arterial stiffness. One more way to reduce cardiovascular risk?

Reklou A, Katsiki N, Karagiannis A, Athyros V.

Curr Vasc Pharmacol. 2019 Jan 20. doi: 10.2174/1570161117666190121102323. [Epub ahead of print]

PMID:
30663570
7.

The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease.

Doumas M, Imprialos K, Dimakopoulou A, Stavropoulos K, Binas A, Athyros VG.

Curr Pharm Des. 2018;24(38):4587-4592. doi: 10.2174/1381612825666190117114305.

PMID:
30652643
8.

Novel Data on the Prevalence, Identification, Scouting, and Treatment of Familial Hypercholesterolaemia.

Doumas M, Imprialos K, Stavropoulos K, Athyros VG.

Curr Pharm Des. 2018;24(31):3597-3598. doi: 10.2174/138161282431181224144112.

PMID:
30642238
9.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
10.

Metabolic syndrome: joint diagnostic criteria and links with comorbidities.

Katsiki N, Doumas M, Athyros V.

Hormones (Athens). 2019 Mar;18(1):107-108. doi: 10.1007/s42000-018-0074-9. Epub 2018 Oct 27. No abstract available.

PMID:
30368688
11.

Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation.

Athyros VG, Katsiki N, Dimakopoulou A, Patoulias D, Alataki S, Doumas M.

Curr Pharm Des. 2018;24(31):3638-3646. doi: 10.2174/1381612824666181009100517.

PMID:
30306859
12.

Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

Rizos CV, Elisaf MS, Skoumas I, Tziomalos K, Kotsis V, Rallidis L, Garoufi A, Athyros VG, Skalidis E, Kolovou G, Koutagiar I, Papagianni M, Antza C, Katsiki N, Ganotakis E, Liberopoulos EN.

Atherosclerosis. 2018 Oct;277:308-313. doi: 10.1016/j.atherosclerosis.2018.08.017.

PMID:
30270064
13.

Antihypertensive therapy in acute ischemic stroke: where do we stand?

Georgianou E, Georgianos PI, Petidis K, Athyros VG, Sarafidis PA, Karagiannis A.

J Hum Hypertens. 2018 Dec;32(12):799-807. doi: 10.1038/s41371-018-0105-7. Epub 2018 Sep 19.

PMID:
30232398
14.

An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

Rizos CV, Athyros V, Bilianou E, Chrousos G, Garoufi A, Kolovou G, Kotsis V, Rallidis L, Skalidis E, Skoumas I, Tziomalos K, Liberopoulos EN.

Hormones (Athens). 2017 Jul;16(3):306-312. doi: 10.1007/BF03401525. Epub 2017 Nov 30.

PMID:
30091117
15.

SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature.

Patoulias D, Imprialos K, Stavropoulos K, Athyros V, Doumas M.

Curr Clin Pharmacol. 2018;13(4):261-272. doi: 10.2174/1574884713666180807150509.

PMID:
30084335
16.

Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome.

Stavropoulos K, Sotiriadis A, Patoulias D, Imprialos K, Dampali R, Athyros V, Dinas K.

Gynecol Endocrinol. 2018 Dec;34(12):1019-1021. doi: 10.1080/09513590.2018.1480713. Epub 2018 Jun 22.

PMID:
29933704
17.

Statins and substantially increased ALT values at baseline.

Athyros VG, Katsiki N, Mikhailidis DP.

Cardiovasc Ther. 2018 Oct;36(5):e12444. doi: 10.1111/1755-5922.12444. Epub 2018 Jun 30. No abstract available.

PMID:
29883041
18.

Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints.

Doumas M, Imprialos Κ, Stavropoulos K, Reklou A, Sachinidis A, Athyros VG.

Curr Pharm Des. 2018;24(17):1879-1886. doi: 10.2174/1381612824666180604113653.

PMID:
29865997
19.

The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data.

Anagnostis P, Siolos P, Christou K, Gkekas NK, Kosmidou N, Athyros VG, Karagiannis A.

Hormones (Athens). 2018 Mar;17(1):83-95. doi: 10.1007/s42000-018-0017-5. Epub 2018 Apr 24. Review.

PMID:
29858866
20.

Diabetes and lipid metabolism.

Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, Karagiannis A.

Hormones (Athens). 2018 Mar;17(1):61-67. doi: 10.1007/s42000-018-0014-8. Epub 2018 Apr 16. Review.

PMID:
29858856

Supplemental Content

Loading ...
Support Center